According to @StockMKTNewz, citing The Wall Street Journal, Hims & Hers Health (HIMS) has launched a lab testing offering integrated with Quest Diagnostics (DGX). The report states customers can access testing at over 1,000 Quest sites nationwide, receive results on the Hims platform, and consult with providers there (The Wall Street Journal via @StockMKTNewz). Pricing is 199 USD per year for one blood draw covering 50 biomarkers, or 499 USD for two blood draws covering 120 biomarkers, spanning heart health, metabolism, hormones, inflammation, and stress (The Wall Street Journal via @StockMKTNewz). No cryptocurrency or digital-asset impact was mentioned in the cited report (The Wall Street Journal via @StockMKTNewz).

According to The White House's Twitter account, WHOOP CEO and Founder Will Ahmed emphasized the urgent need to address health issues in the US through proactive steps, as highlighted in the 'Make America Healthy Again' campaign. This renewed national focus on health technology could boost trading sentiment for health tech stocks and related crypto health tokens, such as those supporting wearable health data on blockchain platforms. Market participants should monitor WHOOP and similar digital health companies for potential partnership announcements, as these could trigger volatility and volume spikes in both equity and crypto markets tied to health innovation (source: The White House, May 23, 2025).